Identifying risk factors for persistent COVID in children
“We found that in some children, illness with COVID-19 was associated with reporting,” said lead investigator Stephen Freedman, MDCM, MSc at the Cumming School of Medicine at the University of Calgary and Alberta Health Services. Report persistent symptoms after 3 months. “Our results suggest that appropriate guidance and monitoring is needed, especially for children at high risk for persistent COVID.”
The study included 1,884 children with COVID-19 who were followed for 90 days for risk factors for the disease. Persistent COVID is found in nearly 10% of hospitalized children and 5% of children discharged after ED.
“The reported rate of persistent COVID in adults was significantly higher than what we found in children,” said Co-Principal Investigator Nathan Kuppermann, MD, MPH, from the University of California, School of Medicine Davis, Sacramento said. “Our findings may inform public health policy decisions regarding children’s COVID-19 mitigation strategies and protracted COVID screening approaches in people with severe infections.”
The most commonly reported persistent symptoms or risk factors in children were weakness, cough, shortness of breath, or shortness of breath.
“Our finding that children with more initial COVID-19 symptoms are at higher risk for persistent COVID are consistent with studies in adults,” said Co-Investigator Todd Florin, MD, MSCE , from the Ann & Robert H. Lurie Children’s Hospital, said the University of Chicago Feinberg School of Medicine and Northwestern University. “Unfortunately, there is no known treatment for persistent COVID in children and further research is needed in this area. However, if symptoms are significant, treatment targets the symptoms. symptoms are most important. Multimodal care is warranted if symptoms affect quality of life.”